News

Heart5d
Severity of mobility limitation and adverse outcomes in heart failure
Background Mobility limitation is prevalent in patients with heart failure (HF), but the dose-response relationship between ...
Opinion
Heart4dOpinion
It is time to treat cannabis as an important risk factor for cardiovascular disease
Legalisation of medical and recreational cannabis commerce is spreading around the world, associated with increased use1 and falling perception of the risk.2 Frequent cannabis use has increased in ...
Heart4d
Impact of air pollution and multimorbidity on the risk of incident atrial fibrillation
Background Emerging evidence suggests associations between air pollution, multimorbidity, and atrial fibrillation (AF), but their interplay remains unclear. We evaluated these relationships in a ...
BMJ3d
Contribution of NOTCH1 genetic variants to bicuspid aortic valve and other congenital lesions
Correspondence to Dr Radoslaw Marek Debiec, Cardiovascular Sciences, University of Leicester College of Medicine Biological Sciences and Psychology, Leicester LE3 9QP, UK; rmd24{at}le.ac.uk Aim The ...
BMJ18h
Opportunities and challenges of implementing computed tomography fractional flow reserve into clinical practice
Correspondence to Dr Edward D Nicol, Departments of Cardiology and Radiology, Royal Brompton and Harefield NHS Foundation Trust, Sydney Street, London, SW3 6NP, UK; e.nicol{at}nhs.net CT-derived ...
BMJ9d
Prognostic implications of left ventricular diastolic dysfunction in moderate aortic stenosis
5 Department of Cardiothoracic Surgery, National Heart Centre Singapore, Singapore 6 Department of Cardiology, National University Heart Centre, Singapore Objective To investigate the prognostic ...
BMJ12d
When absence of evidence equates to evidence of absence: the case of routine use of cerebral embolic protection devices in transcatheter aortic valve implantation
Objectives This updated hierarchical Bayesian meta-analysis aims to integrate the latest randomised controlled trials (RCTs) on the use of cerebral embolic protection (CEP) in transcatheter aortic ...
BMJ3d
Tyrosine kinase inhibitors in chronic myeloid leukaemia and emergent cardiovascular disease
Objectives (1) Describe how the risk of major adverse cardiovascular events (MACE) in individuals with chronic myeloid leukaemia (CML) has evolved; (2) evaluate the risk of MACE associated with the ...
BMJ12d
Reshaping the paradigm: towards holistic cardiovascular risk assessment in older adults
In his song ‘Envelhecer’ (‘Aging’), Arnaldo Antunes states that “the most modern thing there is in this life is to grow old”.1 In this piece, he reframes aging not only as an inevitable biological ...
BMJ1d
Specialist valve clinic: why, who and how?
Guy"s and St Thomas" Hospitals, London SE1 7EH, UK Correspondence to Professor John B Chambers, Guy"s and St Thomas" Hospitals, London SE1 7EH, UK; jboydchambers{at}aol.com If you wish to reuse any or ...
BMJ8d
Management of heart failure with reduced ejection fraction
http://orcid.org/0000-0003-1053-7840Paul M Haydock, http://orcid.org/0000-0002-8126-9583Andrew S Flett To review the pathophysiology of heart failure with reduced ...
BMJ1d
The effect of green Mediterranean diet on cardiometabolic risk; a randomised controlled trial
Objective To examine the residual effect of a green Mediterranean diet, further enriched with green plant-based foods and lower meat intake, on cardiometabolic risk. Methods For the DIRECT-PLUS ...